Michael Lewis Insider Trading $HSGX Ocugen, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael Lewis.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael Lewis. Michael Lewis is Director in HISTOGENICS CORP ($HSGX).

Michael Lewis in Ocugen, Inc.

Trading Symbol: HSGX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael Lewis: Director
Holdings: 4,014,415 shares
Current Value: $6,663,929
Latest Transaction: Feb 11 2019
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael Lewis in Ocugen, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 11 2019HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseM0.011,244,44412,4440
Feb 11 2019HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseM0.01403,8454,0380
Feb 11 2019HSGXHISTOGENICS CORPLewis MichaelDirectorBuyM0.001,244,44405,258,8594 M to 5.3 M (+31.00 %)
Feb 11 2019HSGXHISTOGENICS CORPLewis MichaelDirectorBuyM0.00403,84504,014,4153.6 M to 4 M (+11.19 %)
Oct 11 2018HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseP0.70403,845282,692403,845
Oct 11 2018HSGXHISTOGENICS CORPLewis MichaelDirectorBuyP0.00538,46003,610,5703.1 M to 3.6 M (+17.53 %)
Jun 19 2018HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseA2.9725,00074,25025,000
Jun 14 2017HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseA1.7025,00042,50025,000
Dec 19 2016HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseA1.5810,00015,80010,000
Dec 06 2016HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseC0.002,24300
Dec 06 2016HSGXHISTOGENICS CORPLewis MichaelDirectorBuyC0.00996,77903,072,1102.1 M to 3.1 M (+48.03 %)
Oct 03 2016HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseA2.251,244,4442,799,9990
Oct 03 2016HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseA0.002,24300
Oct 03 2016HSGXHISTOGENICS CORPLewis MichaelDirectorGrantA2.25247,665557,2462,075,3311.8 M to 2.1 M (+13.55 %)
Jun 26 2015HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseA6.8620,000137,20020,000
Jun 03 2015HSGXHISTOGENICS CORPLewis MichaelDirectorSellJ0.0089,44101,827,6661.9 M to 1.8 M (-4.67 %)
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseX0.7611,5028,7420
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseC0.00492,61800
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorOption ExerciseC0.00747,00000
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorSellJ0.0017,38301,917,1071.9 M to 1.9 M (-0.90 %)
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorBuyP11.00394,9184,344,0981,934,4901.5 M to 1.9 M (+25.65 %)
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorSellS11.007928,7121,539,5721.5 M to 1.5 M (-0.05 %)
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorBuyX0.7611,5028,7421,540,3641.5 M to 1.5 M (+0.75 %)
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorBuyC0.00492,61801,528,8621 M to 1.5 M (+47.54 %)
Dec 08 2014HSGXHISTOGENICS CORPLewis MichaelDirectorBuyC0.00747,00001,036,244289.2 K to 1 M (+258.26 %)

Page:   1